What Verdica's 799 score means for ALEMBIC PHARMS LTD
Alembic Pharms Ltd's composite score of 799 out of 850 places the entity in Verdica's "strong" band (740–799), indicating above-average compliance performance across the regulatory dimensions that matter most in pharmaceutical manufacturing and distribution. This score reflects consistent adherence to state pharmacy board standards, FDA requirements, and DEA controls—the three pillars of U.S. pharmaceutical oversight.
A score in the strong band signals that a provider meets baseline expectations and has demonstrated reliable regulatory standing. It is not a perfect score (the "excellent" band starts at 800), but it reflects substantive compliance across multiple oversight bodies. For a business owner or healthcare organization evaluating Alembic Pharms Ltd, a 799 suggests lower regulatory risk compared to entities scoring below 740, but it also indicates room for minor improvement or unresolved compliance nuances. The absence of independent customer reviews means reputation assessment rests entirely on regulatory data; readers should treat the score as a baseline quality signal rather than a comprehensive vendor picture.
How the sub-scores break down
Product Approval (850/850): This perfect sub-score indicates that Alembic Pharms Ltd's products have cleared all required FDA approval pathways. In the pharmacy and pharmaceutical manufacturing sector, a maximal product approval score means drugs or formulations in the entity's portfolio have met premarket review standards, labeling requirements, and manufacturing quality benchmarks set by the FDA. This dimension does not measure sales volume or clinical outcomes—only regulatory authorization. A perfect score here is a strong indicator that the entity's product line is legally cleared for distribution.
Manufacturer Profile (720/850): This sub-score of 720 is the weakest of the three dimensions, though still in acceptable range. Manufacturer profile typically aggregates data on facility inspections, Good Manufacturing Practice (GMP) compliance, ownership structure, and operational history tracked by the FDA and state boards. A score of 720 suggests the manufacturer meets baseline standards but may have minor inspection findings, compliance gaps, or operational patterns flagged by regulators. This is not uncommon in the industry and does not necessarily indicate imminent risk; it often reflects routine audit observations or historical issues that have been or are being addressed.
FDA Compliance (830/850): This strong sub-score reflects adherence to federal pharmaceutical regulations, including adverse event reporting, manufacturing standards, and product labeling. An 830 indicates few or no material violations in FDA records; the entity has demonstrated consistent alignment with federal oversight mechanisms. Minor compliance gaps or documentation issues may account for the 20-point deduction from perfect, but substantive regulatory friction appears absent.
What regulators track for pharmacy providers
State boards of pharmacy monitor licensure status, facility operations, record-keeping, and adherence to state-specific practice standards. The FDA tracks manufacturing facilities through inspections (Form 483 observations and warning letters), product approvals, and adverse event reports filed through MedWatch and other systems. The DEA monitors controlled substance handling, inventory accuracy, and diversion prevention for entities holding DEA registration.
Verdica's composite methodology weights these three data streams to flag high-risk providers (those with warning letters, license suspensions, significant GMP violations, or controlled substance discrepancies) and recognize those with clean records. A decline in any sub-score typically reflects inspection findings, unresolved compliance notices, or regulatory actions. Movement within the strong or excellent bands is usually driven by minor findings or process improvements rather than serious violations.
Bottom line
Alembic Pharms Ltd scores in the strong regulatory compliance band, with particularly robust product approval and federal compliance records. Before contracting with this manufacturer, verify that its product portfolio aligns with your needs and confirm current licensure status through your state board of pharmacy—regulatory snapshots can shift, and this score is current only to Verdica's last update.